about
Hyperbaric oxygen therapy for Bell's palsyHyperbaric oxygen therapy for Bell's palsyEfficacy of live zoster vaccine in preventing zoster and postherpetic neuralgiaRamsay Hunt syndrome.Varicella-zoster virusAnimal models of varicella zoster virus infectionNeurological disease produced by varicella zoster virus reactivation without rashVaricella zoster vaccines and their implications for development of HSV vaccinesRecommendations for the Management of Herpes ZosterThe variegate neurological manifestations of varicella zoster virus infection.Varicella-zosterVirus vasculopathy and stroke: an under-recognized cause and treatment target.The expanding spectrum of herpesvirus infections of the nervous system.Polymerase chain reaction as a diagnostic adjunct in herpesvirus infections of the nervous system.Varicella-zoster virus: atypical presentations and unusual complications.Zoster sine herpete: virologic verification by detection of anti-VZV IgG antibody in CSF.Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latencySubclinical reactivation of varicella zoster virus in all stages of HIV infection.Review: The neurobiology of varicella zoster virus infection.Recombination of Globally Circulating Varicella-Zoster VirusMolecular methods for diagnosis of viral encephalitisGenotypic analysis of varicella-zoster virus and its seroprevalence in Finland.Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system.Use of Saliva to Identify Varicella Zoster Virus Infection of the GutChronic active varicella zoster virus infection.The Relief of Unilateral Painful Thoracic Radiculopathy without Headache from Remote Spontaneous Spinal Cerebrospinal Fluid Leak.The challenging patient with varicella-zoster virus diseaseComplications of varicella zoster virus reactivation.Issues in the Treatment of Neurological Conditions Caused by Reactivation of Varicella Zoster Virus (VZV).Pathogenesis and current approaches to control of varicella-zoster virus infections.Varicella zoster virus meningitis with hypoglycorrhachia in the absence of rash in an immunocompetent woman.Clinical and molecular aspects of varicella zoster virus infection.Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons.EFNS-ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system.Neurological complications of varicella zoster virus reactivation.Test battery of cranial nerves VII and VIII for assessing herpes zoster oticus.Herpes zoster - typical and atypical presentations.Localization of VZV in saliva of zoster patients.Cerebrospinal fluid viral load and biomarkers of neuronal and glial cells in Ramsay Hunt syndrome.Herpes zoster meningoencephalitis without rash: varicella zoster virus DNA in CSF.
P2860
Q24203705-E021827F-1CE5-495F-809C-10DE93B2A907Q24242387-D9045D86-2AE0-46BB-8AB6-D56EBEEFC07EQ24606799-F2322010-3F10-4AA9-8DD4-80379E9DE0E9Q24672575-543ED2C2-4DFC-4AC1-A716-1CE7B8CA2D5EQ24683811-D29FDF40-1BE7-4B22-AFD7-5674C18C9FF9Q27011703-86519B17-6D66-43C8-B896-E9C3AAEC081FQ27694488-E43EE384-D4B9-4161-853F-4810A4CD52A2Q28280820-25FD16B1-6F3E-4D5B-8C65-30B0C3BF7D5BQ28315869-F0D90860-521F-46BF-B34B-5E4A30D8960BQ33732991-4F737C03-5D54-4785-8D72-886DF7D97859Q33848049-E365278F-3FE7-4677-B32D-3D0FCC3048DDQ34015853-47C58C81-1F7B-48D6-837F-14E7905B2415Q34369538-338797D0-0D75-4864-91B9-2BBC430FC436Q34369547-74EBDE27-88CE-4D80-A7F9-76B6E1B227BFQ34527694-36170966-A1E2-4A4A-BC19-7224A80C4096Q34555408-FE010A73-9497-4599-9477-0DBEF7BEF90FQ34594761-7B0872AE-D3CB-4621-B3F5-8D28627D68A9Q35223284-96173F18-914A-4DB4-A2C5-981BD181D22CQ35223289-DC9ACDE1-BE18-4ED7-9E06-25237BF85E20Q35758661-BEC194B0-E596-4429-9591-F2951DE6527CQ35920649-B4FFEF55-BB78-45F8-A916-42AA392F8385Q36095164-6C6E4827-09E1-4866-A089-579CEE82E179Q36142649-4C4A7DCF-5489-4E90-BFCE-DC4A3C559BA3Q36167494-8F1C2A1C-2E89-4B1E-AA37-4E63F5CAA86EQ36170567-0DD8B709-1507-4EE9-86EE-6C112211D448Q36997002-EDD579EF-7F07-42DB-A41D-903D0A587E06Q37040149-C234E074-0CC5-49DB-9CC0-F1B3822B94C7Q37119278-02B80A41-DDAC-4193-9BFC-7E1EACC4FEE0Q37136450-312D4BAE-6822-47AD-AF7E-FC00E5EC7DE0Q37263293-81F8D744-846B-41F1-8E46-3784C382FC4AQ37369638-7851B88D-DF1C-48AF-8E2E-19646BF8E048Q37436473-10226A32-F45D-44A3-A0C0-9C4090F984FAQ37710719-7AA63A8D-C68D-47BD-803F-A07FD576FC7DQ38033652-3913771A-1A8A-4C93-A638-05396F5042BAQ38208988-0D1475CE-C130-4FA9-B80F-543ABC8CD859Q38266842-57FB8141-5E5E-4E2A-962E-04FB0EEAEFACQ40187065-D68A2093-6F92-486F-B097-C3EDB50826B4Q40291612-622E4465-EBBA-4BC4-B9A0-3BD6CA86AC82Q40535575-F279A9A9-C861-417D-B6A5-7EAC9BD8B426Q41350068-48162DB3-F988-463C-BD1E-52E70AC1771A
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Zoster sine herpete, a clinical variant.
@en
type
label
Zoster sine herpete, a clinical variant.
@en
prefLabel
Zoster sine herpete, a clinical variant.
@en
P2093
P2860
P356
P1433
P1476
Zoster sine herpete, a clinical variant.
@en
P2093
Gwaltney JM Jr
Mahalingam R
Schneck SA
P2860
P304
P356
10.1002/ANA.410350505
P577
1994-05-01T00:00:00Z